Stockreport

Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform

Surmodics, Inc.  (SRDX) 
Last surmodics, inc. earnings: 4/29 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: surmodics.gcs-web.com/investor-overview
PDF Analysis of 160 patients with acute, subacute, or chronic symptoms of thrombotic limb ischemia receiving thromboemboli removal treatment with the Pounce™ Thrombectomy Pl [Read more]